January 19, 2019
14 min watch
Save

VIDEO: Anatomic results achieved with brolucizumab maintained

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WAIKOLOA, Hawaii — At Retina 2019, Sophie J. Bakri, MD, of the Mayo Clinic in Rochester, Minnesota, gives an update on phase 3 studies of brolucizumab for treatment of neovascular AMD.